Skip to content

Clinical trials

Phase 3 Cognitive Dysfunction trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 3 Status: Unknown status Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20093
20171
20181
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beersheva Mental Health Center1
Charite University, Berlin, Germany1
Groupe Hospitalier Pitie-Salpetriere1
Hospital de Clinicas de Porto Alegre1
Nanjing Yoko Biomedical Co., Ltd.1
The University of The West Indies1
Tim Lau1
Universidad de Colima1
University Hospital Muenster1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction9
Bipolar Disorder1
Consciousness Disorders1
Craniocerebral Trauma1
Dementia1
Fatigue1
Lewy Body Disease1
Neoplasms1
Persistent Vegetative State1
Schizophrenia1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.